Fulgent Genetics to Announce Third Quarter 2022 Financial Results on Monday November 7, 2022
businesswire.com
news
2022-10-20 00:00:00

October 20, 2022 04:03 PM Eastern Daylight Time TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ('Fulgent Genetics' or the 'Company'), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced that it will release its third quarter 2022 financial results after the market closes on Monday November 7, 2022. Management will host a conference call for the investment community the same day at 4:30 PM ET (1:30 PM PT) to discuss the results and answer questions.
